ISRLU logo
ISRLU NASDAQ US

Israel Acquisitions Corp - Unit

N/A · N/A Website · IPO Jan 2023
$11.02
▲ +$0.00 (+0.00%)
6
Quality Score
fail
Mkt Cap
$78.5M
P/E
58.8
ROE
3.4%
D/E
76.05
Beta
0.04
52W
$11–$14

Price Chart

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0…
Revenue
Net Income $811K $695K $67K -$238K -$180K

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 3.4% 4.1% 3.4% 3.4% 3.4% 3.4%
P/E (TTM) 60.46 34.22 59.89 59.41 59.51 58.84
Net Margin
Gross Margin
D/E Ratio 76.05 56.25 76.05 76.05 76.05 76.05
Current Ratio 1.27 1.32 1.27 1.27 1.27 1.27

Key Ratios

ROA (TTM)
2.9%
P/B
1.9
EPS (TTM)
$0.09
CF/Share
$0.23
52W High
$14.00
52W Low
$11.02
$11.02 52-Week Range $14.00

Financial Health

Free Cash Flow
-$103K
Net Debt
$1.8M
Cash
$64K
Total Debt
$1.8M
As of Sep 30, 2025

How does ISRLU compare to N/A peers?

Peer group: Micro-cap N/A (All) · 453 companies

ISRLU valuation vs N/A peers

P/E ratio
58.8
4% above peers (56.5)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (6.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.9
43% above peers (1.3)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (19.6%)
vs Peers
vs Industry
Low yield

ISRLU profitability vs N/A peers

ROE
3.4%
24% above peers (2.8%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (0.8%)
vs Peers
vs Industry
Weak
Gross margin
0% below peers (63.5%)
vs Peers
vs Industry
Weak
ROA
2.9%
11% above peers (2.6%)
vs Peers
vs Industry
Weak

ISRLU financial health vs N/A peers

D/E ratio
76.1
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.3
12% above peers (1.1)
vs Peers
vs Industry
In line
Beta
0.0
84% above peers (0.0)
vs Peers
vs Industry
More volatile

ISRLU fundamentals radar

ISRLU Peer median Industry

ISRLU profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ISRLU vs peers: key metrics

Top Holders

Top 5: 0.04%
Clear Street Group Inc.
0.03%
$45K
UBS Group AG
0.01%
$13K
As of Sep 30, 2025

Latest News

No related news yet